2m 2m 2m 2m 2m 2m 2m
Anika Therapeuti (ANIK)
NASDAQ
$21.09-$0.70 (-3.19%)
Price as of Aug 21, 2026 7:58 PM EDT- $291.5MMarket Cap
- 125.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Anika Therapeuti (ANIK)
$21.09-$0.70 (-3.19%)
ANIK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.78 | ||
Change | +$0.44 (+2.06%) | ||
Open | $21.38 | ||
High | $22.32 | ||
Low | $21.01 | ||
Previous Close | $21.34 | ||
Volume | 340,432 | ||
30-Day Average Volume | 125,253 | ||
1-Week Change | 1.30% | ||
1-Month Change | 43.67% | ||
1-Year Change | 125.70% | ||
3-Year Change | 17.35% | ||
5-Year Change | -49.41% | ||
Fundamentals | |||
Shares Outstanding | 13.4M | ||
Total Assets | $183.5M | ||
Market Cap | $291.5M | ||
Enterprise Value | $253.1M | ||
Period: QTR TTM FY | |||
Revenue | $32.6M | ||
Net Income | $3.3M | ||
Free Cash Flow | -$2.1M | ||
EBIT | $3.4M | ||
EBITDA | $4.9M | ||
Net Working Capital | $77.0M | ||
EPS | $0.24 | ||
Enterprise Value/EBITDA | 52 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 2 | ||
P/E | 91 | ||
PEG | 1 | ||
Price/Free Cash Flow | -137 | ||
Price/Operating Cash Flow | -426 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue